Latest Genentech Stories
Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that Naseem Buckley of Genentech will speak at Pharmica’s SharePoint Conference for
While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON,
Former Genentech executive to lead Moderna's first venture company, focused exclusively in novel biology for oncology drug development CAMBRIDGE, Mass., July 1, 2014 /PRNewswire/ --
The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16,
INCLINE VILLAGE, Nev., June 10, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
Roche/Genentech's Avastin Continues to Garner the Greatest Physician-Reported Patient Share in DME Due to Its Low Relative Cost, According to Findings from Decision Resources Group BURLINGTON,
Ultimate Award Recipient Rackspace and Finalists including Cisco, ConAgra Foods, Genentech and Tata Consultancy Services focus on programs to acquire, grow and retain employees, manage change, and
--PDL's Revolutionary Antibody Technology Provided Basis for Eight Successful Drugs Currently on the Market-- INCLINE VILLAGE, Nev., May 6, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
Reduction in Exacerbations Remains the Top Driver of Physician Prescribing Choice in Moderate to Severe Asthma, According to Findings from Decision Resources Group BURLINGTON, Mass., May 1,
Improved Overall Survival and Delayed Disease Progression are the Greatest Unmet Needs in this Population, According to Findings from Decision Resources Group BURLINGTON, Mass., April 10, 2014
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.